Coronary Artery Disease - From Genetics to Drug Development

Coronary Artery Disease - From Genetics to Drug Development

University of Ottawa Heart Institute via YouTube Direct link

Noncoding regions

11 of 32

11 of 32

Noncoding regions

Class Central Classrooms beta

YouTube videos curated by Class Central.

Classroom Contents

Coronary Artery Disease - From Genetics to Drug Development

Automatically move to the next video in the Classroom when playback concludes

  1. 1 Intro
  2. 2 Genetic studies
  3. 3 What are genetics
  4. 4 Affymetrix chips
  5. 5 Polygen
  6. 6 Risk variance
  7. 7 Risk factors
  8. 8 New biology
  9. 9 Complex disease
  10. 10 Source of study
  11. 11 Noncoding regions
  12. 12 G1 studies
  13. 13 Computational approaches
  14. 14 Pathway analysis
  15. 15 Other studies
  16. 16 MicroRNAs
  17. 17 Mendelian evangelization
  18. 18 MRAS
  19. 19 Cholesterol
  20. 20 LDL
  21. 21 Functional genomics
  22. 22 Target discovery
  23. 23 Reducing triglycerides
  24. 24 Homozygous FH
  25. 25 Antisense
  26. 26 Security randomization
  27. 27 Genetics and coronary disease
  28. 28 Genetic risk score
  29. 29 Risk alleles
  30. 30 Polygenic risk
  31. 31 Thank you
  32. 32 Question

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Someone learning on their laptop while sitting on the floor.